Acadian Asset Management LLC Mirum Pharmaceuticals, Inc. Transaction History
Acadian Asset Management LLC
- $32.2 Billion
- Q3 2024
A detailed history of Acadian Asset Management LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 1,504 shares of MIRM stock, worth $70,612. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,504Holding current value
$70,612% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
192Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$308 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$210 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$162 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$152 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$144 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.73B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...